ZA853351B - 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it - Google Patents

2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it

Info

Publication number
ZA853351B
ZA853351B ZA853351A ZA853351A ZA853351B ZA 853351 B ZA853351 B ZA 853351B ZA 853351 A ZA853351 A ZA 853351A ZA 853351 A ZA853351 A ZA 853351A ZA 853351 B ZA853351 B ZA 853351B
Authority
ZA
South Africa
Prior art keywords
ethoxycarbonylamino
benzylamino
fluoro
amino
production
Prior art date
Application number
ZA853351A
Other languages
English (en)
Inventor
Helmut Hettiche
Juergen Engel
Peter Emig
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of ZA853351B publication Critical patent/ZA853351B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10Polyhydroxy carboxylic acids
    • C07C59/105Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA853351A 1984-05-05 1985-05-03 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it ZA853351B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (1)

Publication Number Publication Date
ZA853351B true ZA853351B (en) 1985-12-24

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA853351A ZA853351B (en) 1984-05-05 1985-05-03 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it

Country Status (25)

Country Link
US (1) US4673666A (xx)
EP (1) EP0160865B1 (xx)
JP (1) JPS60239469A (xx)
KR (1) KR850008678A (xx)
AT (1) ATE33638T1 (xx)
AU (1) AU4194385A (xx)
BG (1) BG44537A3 (xx)
CA (1) CA1263398A (xx)
CS (1) CS248743B2 (xx)
DD (1) DD236927A5 (xx)
DE (2) DE3416609A1 (xx)
DK (1) DK157016C (xx)
ES (1) ES8603423A1 (xx)
FI (1) FI80443C (xx)
GR (1) GR851065B (xx)
HU (1) HU193753B (xx)
IE (1) IE57766B1 (xx)
IL (1) IL75086A (xx)
MC (1) MC1651A1 (xx)
NO (1) NO851772L (xx)
PL (1) PL253202A1 (xx)
PT (1) PT80386B (xx)
SU (1) SU1398772A3 (xx)
YU (1) YU71785A (xx)
ZA (1) ZA853351B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152168A2 (en) 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
WO2009152142A1 (en) * 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Sulfonate salts of flupirtine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate

Also Published As

Publication number Publication date
PT80386A (de) 1985-06-01
DK157016B (da) 1989-10-30
GR851065B (xx) 1985-11-25
DE3416609A1 (de) 1985-11-07
FI851752A0 (fi) 1985-05-03
EP0160865A3 (en) 1986-03-12
DK198785D0 (da) 1985-05-02
IE57766B1 (en) 1993-03-24
DK157016C (da) 1990-03-26
HUT37758A (en) 1986-02-28
FI851752L (fi) 1985-11-06
ES542817A0 (es) 1985-12-16
EP0160865A2 (de) 1985-11-13
NO851772L (no) 1985-11-06
KR850008678A (ko) 1985-12-21
ATE33638T1 (de) 1988-05-15
BG44537A3 (en) 1988-12-15
PL253202A1 (en) 1986-07-15
AU4194385A (en) 1985-11-07
MC1651A1 (fr) 1986-04-07
DK198785A (da) 1985-11-06
HU193753B (en) 1987-11-30
ES8603423A1 (es) 1985-12-16
IL75086A0 (en) 1985-09-29
JPS60239469A (ja) 1985-11-28
JPH0144185B2 (xx) 1989-09-26
EP0160865B1 (de) 1988-04-20
IL75086A (en) 1988-03-31
PT80386B (de) 1987-04-16
DE3562242D1 (en) 1988-05-26
FI80443C (fi) 1990-06-11
SU1398772A3 (ru) 1988-05-23
IE851117L (en) 1985-11-05
CA1263398A (en) 1989-11-28
DD236927A5 (de) 1986-06-25
CS248743B2 (en) 1987-02-12
FI80443B (fi) 1990-02-28
YU71785A (en) 1988-02-29
US4673666A (en) 1987-06-16

Similar Documents

Publication Publication Date Title
DE3163867D1 (en) Novel substituted pyrazinyl-1,2,4-oxadiazol-5-ones, a process for preparing same and a pharmaceutical composition containing same
HUT37410A (en) Process for the production of benzothiazole- and benzothiophene-derivatives, as well as of therapeutic preparations containing them as agent
PH21834A (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
ZA853351B (en) 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it
HU913216D0 (en) Process for the production of saturated hydroxy-alkyl-kinoline acids, and of medical preparations containing them
EP0044453A3 (en) New benzisoselenazolones, process for producing the same and pharmaceutical preparations containing the same
ES8801198A1 (es) Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol
EP0228701A3 (en) 2-iodo-perfluoro-2-methylathanes, process for their production and their application
HU913430D0 (en) 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production
HUT35479A (en) Pesticides containing benzoyl-urea-derivatives and process for the production of the benzoyl-urea-derivatives, as well as of pharmaceutucal preparations containing them
GB2106109B (en) Novel polycyclic polyazaheterocycles, processes for their manufacture and pharmaceutical preparations containing them
GB8727814D0 (en) Process for sterilising packing material
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
CS346691A3 (en) Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids
IL65541A0 (en) Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
ZA815621B (en) Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them
ZA857144B (en) Benzazole derivatives,processes for their production and pharmaceutical preparations containing such compounds and the use thereof
EP0216585A3 (en) 2,6,7-trisubstituted-3-methylenebicyclo û3.3.0¨octanes and process for production thereof
HU904211D0 (en) Process for the production of medical preparations containing 10-amino-5,6-dihydro-11h-dibenzo/b,e/azepin-6,11-dion and its derivatives
IL69624A0 (en) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinolines and their preparation
IE873394L (en) Material for treatment of ammonia.
DE3267376D1 (en) Quinidines, process for their preparation and their pharmaceutical application
ZA846432B (en) 7alpha-substituted 3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,process for their production,and pharmaceutical preparations containing same
GB2155482B (en) Process for the production of protein containing material
HU202408B (en) Process for producing leather-regenerating extracts, and pharmaceutical compositions containing them